| |
Cost-of-illness study of T2DM Colombia
|
Cost-of-illness study of T2DMIran
|
Rosibel de los Angeles T2DM Mexico
|
CODE-2 B. Jonsson T2DM Europe
|
Luciana R. Bahia T2DM Brazil
|
Natalie B. Borges T2DM Brazil
|
|---|
|
Year of publication
|
2009
|
2011
|
2010
|
2002
|
2011
| |
|
Total cost*
|
2.7 billion
|
3.78 billion
|
4.5 billion
|
EUR 29 billion
|
––
|
––
|
|
Total annual cost
|
847
|
1707
|
3194**
|
EUR
|
2108
|
1844
|
|
per patient*
| | | |
2834**
| | |
|
Indirect cost
|
66%
|
51%
|
––
|
––
|
33%
|
45%
|
|
Direct cost
|
34%
|
49%
|
––
|
––
|
63%
|
55%
|
|
Medication
|
47%
|
46%***
|
––
|
7%
|
48%
|
42%
|
|
Laboratory
|
––
|
––
|
––
|
21%
|
––
|
34%****
|
|
Procedures and
|
––
|
––
|
18%
|
55%
|
––
|
14%
|
|
Hospitalizations Consultations
|
––
|
––
|
––
|
18%
|
––
|
4%
|
- *The costs in all studies are shown in US$, except where indicated.
- **Indirect costs were not calculated in these studies.
- ***This percentage refers only to patients without complications.
- ****This percentage refers to the cost of laboratory exams (7%) added to those of strips (27%).
